Here are 20 key notes on orthopedic and spine device companies over the past week.
Amedica entered a debt exchange agreement with Riverside Merchant Partners, Hercules Technology III and Hercules Capital.
Anika Therapeutics named Stephen R. Mascioli, MD, MPH, CMO, and Dana M. Alexander COO.
CareCredit, a provider of patient financing, is collaborating on a new program with DePuy Synthes Mitek Sports Medicine.
William D. Smith, MD, of University Medical Center in Las Vegas, performed Nevada's first procedure involving Expanding Orthopedics' FLXfit expandable cage.
Implanet received FDA clearance and CE mark for its Jazz Lock implant.
Interventional Spine plans to launch a new line of Opticage Lumbar Fusion implant products.
InVivo Therapeutics added University of Virginia Health System in Charlottesville as a clinical site for the INSPIRE study.
Joseph C. McGinley, MD, PhD, a radiologist and president of McGinley Orthopedics, received recognition for his intellisense orthopedic drill.
The FDA issued 510(k) clearances for K2M's MESA Mini Spinal System and DENALI Mini Spinal System.
Medovex entered into an international distribution agreement with Innosurge.
Medtech sold 10 new ROSA robots during the company's third fiscal quarter of 2016.
Medtronic said the U.S. Treasury Department's temporary and proposed rules on tax inversions won't have a material financial impact based on the company's preliminary review.
OrtoWay AB expanded usage of its OrtoWell Distractor to spinal tumor removal and trauma surgery.
Ortho Kinematics received ISO 13485:2003 certification.
Premia Spine introduced its ProMIS Fixation System.
Analysts expect Stryker to report revenue for this year to reach almost $11.06 billion, up from $9.95 billion last year.
Surgical Theater introduced its virtual reality visualization platform for neurosurgery.
TranS1 appointed Brandon Arthurs its new vice president of research and development.
Tyber Medical was approved for a $362,500 loan from the Pennsylvania Industrial Development Authority.
Zyga Technology enrolled the first four patients in its EVoluSIon Clinical Study.